Predictors of End-stage Renal Disease in the Urban Poor

被引:0
|
作者
Hall, Yoshio N. [1 ,5 ]
Choi, Andy I. [2 ,3 ,4 ]
Xu, Ping [1 ]
Smith, Nicholas L. [5 ]
Boyko, Edward J. [5 ]
机构
[1] Univ Washington, Kidney Res Inst, Dept Med, Seattle, WA 98104 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
[5] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA
关键词
End-stage renal disease; chronic kidney disease; urban poor; race or ethnicity; public health care; disparities; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; RACIAL-DIFFERENCES; RISK-FACTORS; PROTEINURIA; HIV; OUTCOMES; ASSOCIATION; DISPARITIES; PROGRESSION;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We sought to examine the influence of social and clinical factors on risk of progression of chronic kidney disease (CKD) to end-stage renal disease (ESRD) in the urban poor. We studied 15,353 individuals with moderate-to-advanced CKD who received ambulatory care within a large public health system during 1996-2005. The primary outcome was progression to ESRD. Overall, 559 cases of ESRD occurred over a median follow-up of 2.8 years. Among traditional predictors of ESRD, younger age, male sex, non-White race/ethnicity, public health insurance coverage, diabetes, lower kidney function, higher proteinuria, lower hemoglobin level, and lower serum albumin concentration were significantly associated with a higher adjusted ESRD risk (p<.001 for all). There was no significant association between HIV/AIDS (p=.07), viral hepatitis (p=.11), or non-English language (p=.27) and ESRD risk. Our results highlight the importance of addressing traditional risk factors for progressive CKD to reduce the disproportionate burden of ESRD among disadvantaged populations.
引用
收藏
页码:1686 / 1700
页数:15
相关论文
共 50 条
  • [11] Clostridium difficile Infection Is Associated With Poor Outcomes in End-Stage Renal Disease
    Pant, Chaitanya
    Deshpande, Abhishek
    Anderson, Michael P.
    Sferra, Thomas J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (02) : 529 - 532
  • [12] Thyroid disease in end-stage renal disease
    Rhee, Connie M.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06) : 621 - 630
  • [13] Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis
    Xiong, Jiachuan
    He, Ting
    Wang, Min
    Nie, Ling
    Zhang, Ying
    Wang, Yiqin
    Huang, Yunjian
    Feng, Bing
    Zhang, Jingbo
    Zhao, Jinghong
    JOURNAL OF NEPHROLOGY, 2019, 32 (05) : 791 - 802
  • [14] End-stage renal disease and thrombophilia
    Bauer, Alexander
    Limperger, Verena
    Nowak-Goettl, Ulrike
    HAMOSTASEOLOGIE, 2016, 36 (02): : 103 - 107
  • [15] Cardiovascular disease in end-stage renal disease
    Park, Jung Tak
    Oh, Hyung Jung
    Kang, Shin-Wook
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2013, 56 (07): : 576 - 582
  • [16] Chronic inflammation in end-stage renal disease and dialysis
    Cobo, Gabriela
    Lindholm, Bengt
    Stenvinkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 35 - 40
  • [17] UMOD as a susceptibility gene for end-stage renal disease
    Reznichenko, Anna
    Boeger, Carsten A.
    Snieder, Harold
    van den Born, Jacob
    de Borst, Martin H.
    Damman, Jeffrey
    van Dijk, Marcory C. R. F.
    van Goor, Harry
    Hepkema, Bouke G.
    Hillebrands, Jan-Luuk
    Leuvenink, Henri G. D.
    Niesing, Jan
    Bakker, Stephan J. L.
    Seelen, Marc
    Navis, Gerjan
    BMC MEDICAL GENETICS, 2012, 13
  • [18] The epidemiology of atrial fibrillation in end-stage renal disease
    Korantzopoulos, Panagiotis
    Liu, Tong
    Letsas, Konstantinos P.
    Fragakis, Nikolaos
    Kyrlas, Konstantinos
    Goudevenos, John A.
    JOURNAL OF NEPHROLOGY, 2013, 26 (04) : 617 - 623
  • [19] Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease
    Rhee, Jinnie J.
    Ding, Victoria Y.
    Rehkopf, David H.
    Arce, Cristina M.
    Winkelmayer, Wolfgang C.
    BMC NEPHROLOGY, 2015, 16
  • [20] Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes
    Soohoo, Melissa
    Moradi, Hamid
    Obi, Yoshitsugu
    Rhee, Connie M.
    Gosmanova, Elvira O.
    Molnar, Miklos Z.
    Kashyap, Moti L.
    Gillen, Daniel L.
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (06):